Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$368.04K$368.04Kderivedno prior Q4 2013 on file Net Income-$2.01M-$2.01MderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Cash Flowderived$65,777−74.2% Free Cash Flowderived$65,776−74.2% ended Dec 31, 2014 · filed Mar 31, 2015 · 90 d after period end